Literature DB >> 19675453

Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.

Sebastian Aulmann1, Zeinab Elsawaf, Roland Penzel, Peter Schirmacher, Hans Peter Sinn.   

Abstract

Low-grade precursor lesions, such flat epithelial atypia (FEA), low-grade ductal carcinoma in situ (lg-DCIS), and lobular neoplasia (LN) often coexist with invasive tubular carcinomas (TCs) of the breast. To evaluate a possible clonal relationship, we have examined a series of 27 TC and the surrounding putative precursor lesions using loss of heterozygosity analysis and mitochondrial DNA sequencing. In these lesions (22 FEA, 10 lg-DCIS, 3 LN), loss of heterozygosity was most frequently observed on the long arm of chromosome 16 as well as at chromosome 8p21, 3p14, 1p36 and 11q14 with a high degree of homology of allelic losses between FEA, lg-DCIS and tubular carcinomas. In the adjacent invasive tubular carcinomas, mitochondrial DNA sequencing revealed identical mutation patterns in 50% of the lg-DCIS and in 12 of 21 (57%) informative cases of FEA. No direct association was seen between TC and LN or columnar cell lesions without nuclear atypia. Our data indicate, that in the majority of cases lg-DCIS and FEA are directly related to tubular breast cancer with a possible precursor role.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675453     DOI: 10.1097/PAS.0b013e3181adfdcf

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.

Authors:  Samar M Said; Daniel W Visscher; Aziza Nassar; Ryan D Frank; Robert A Vierkant; Marlene H Frost; Karthik Ghosh; Derek C Radisky; Lynn C Hartmann; Amy C Degnim
Journal:  Cancer       Date:  2015-01-13       Impact factor: 6.860

3.  [Ductal and lobular preneoplasia: role in breast cancer development].

Authors:  S Aulmann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 4.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

5.  Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.

Authors:  Julie M Jorns; Dafydd G Thomas; Patrick N Healy; Stephanie Daignault; Tammi L Vickery; Jacqueline E Snider; Elaine R Mardis; Sherri R Davies; Matthew J Ellis; Daniel W Visscher
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

6.  Is the outcome at surgery different when flat epithelial atypia and lobular neoplasia are found in association at biopsy?

Authors:  Mona El Khoury; Lilia Maria Sanchez; Lucie Lalonde; Isabelle Trop; Julie David; Benoît Mesurolle
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

Review 7.  Lobular Carcinoma In Situ.

Authors:  Hannah Y Wen; Edi Brogi
Journal:  Surg Pathol Clin       Date:  2017-12-08

8.  Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.

Authors:  Anoek H J Verschuur-Maes; Cathy B Moelans; Peter C de Bruin; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2014-04-02       Impact factor: 6.730

9.  Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ.

Authors:  Yejin Min; Soo Youn Bae; Hyun-Chul Lee; Jun Ho Lee; Minkuk Kim; Jiyoung Kim; Se Kyung Lee; Won Ho Kil; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

Review 10.  Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?

Authors:  Sarah Strickland; Gulisa Turashvili
Journal:  Curr Oncol       Date:  2022-08-11       Impact factor: 3.109

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.